Anupam Gautam

12PUBLICATIONS
41CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Plant cell and molecular biologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 20, 2026
S1P-S1PR1 signaling impairs CD8+ T cell metabolism and effector function in tumors.

Debashree Basak, Puspendu Ghosh, Anupam Gautam

|Mar 21, 2025
CD38-mediated metabolic reprogramming promotes the stability and suppressive function of regulatory T cells in tumor.

Ishita Sarkar, Debashree Basak, Puspendu Ghosh

|Jan 13, 2025
TIPPo: A User-Friendly Tool for De Novo Assembly of Organellar Genomes with High-Fidelity Data.

Wenfei Xian, Ilja Bezrukov, Zhigui Bao

|Oct 29, 2024
Glut3 promotes cellular O-GlcNAcylation as a distinctive tumor-supportive feature in Treg cells.

Amit Sharma, Garima Sharma, Zhen Gao

|Mar 07, 2024
CD38-RyR2 axis-mediated signaling impedes CD8+ T cell response to anti-PD1 therapy in cancer.

Anwesha Kar, Puspendu Ghosh, Anupam Gautam

|Oct 31, 2023
A comprehension on structure guided alignment dependent 3D-QSAR modelling, and molecular dynamics simulation on 2,4-thiazolidinediones as aldose reductase inhibitors for the management of diabetic complications.

Priyadarshi Gautam, Priya Bisht, Anupam Gautam

Pageof 2

Frequent Collaborators

5 joint publications

Sandip Paul

4 joint publications

Puspendu Ghosh

3 joint publications

Dipanjan Ghosh

3 joint publications

Snehanshu Chowdhury